O'Toole David D 4

What Happened

• David D. O'Toole, Chief Financial Officer of AVITA Medical, was awarded 2,000 shares on June 12, 2026. The filing shows an acquisition at $3.97 per share, totaling $7,940. The grant includes unvested restricted stock units (RSUs).

Key Details

• Transaction date and price: 2026-06-12, 2,000 shares at $3.97/share (total $7,940).
• Transaction type/code: Award/Grant (Form 4 code A).
• Shares owned after transaction: Not specified in the provided summary—see the full SEC filing for post-transaction holdings.
• Footnote: Grant "includes unvested RSUs."
• Filing timeliness: Report filed on 2026-06-12 for a 2026-06-12 transaction (timely).

Context

• RSU grants are typically compensation that vests over time; unvested RSUs do not represent immediately tradable shares unless vested. This is an award (an acquisition) rather than an open-market purchase or sale, and is commonly part of executive pay packages. Check the full Form 4 or company disclosures for vesting schedule and any additional details.